摘要
目的:观察绞股蓝皂苷(GP)对晚期糖基化终末产物(AGEs)诱导的人肾小球系膜细胞(HMCs)增殖及分泌细胞外基质(ECM)的影响。方法:将对数生长期的HMCs分为空白组、模型组、药物组、阳性组。空白组不给予任何诱导和干预,模型组、药物组、阳性组均采用200mg/L的AGEs诱导HMCs,药物组同时给予低、中、高剂量(25、75、150mg/L)的GP干预,阳性组同时给予0.1mmol/L的氨基胍盐酸盐(AG)干预,培养72h。采用MTT法观察各组中HMCs的增殖活性;Western blotting法检测核因子-κB(NF-κB)的表达;Real-Time PCR法检测转化生长因子-β1(TGF-β1)和血小板衍化生长因子-BB(PDGF-BB)m RNA的表达。结果:模型组中,AGEs能够诱导HMCs增殖、促进NF-κB活化及上调TGF-β1、PDGF-BB m RNA的表达,与空白组相比差异有统计学意义(P<0.01);药物组中,GP可以抑制AGEs诱导的HMCs增殖、NF-κB活化及下调TGF-β1、PDGF-BB m RNA的表达,与模型组相比差异有统计学意义(P<0.01)。结论:GP对AGEs培养条件下的HMCs具有一定的保护作用,GP可能通过抑制NF-κB活化及下调TGF-β1、PDGF-BB m RNA的表达,进而减少ECM的分泌和聚集,达到延缓糖尿病肾病进展的作用。
Objective: To observe the effect of Gypenosides(GP) on the proliferation of human mesangial cells(HMCs) and secretion of extracellular matrix(ECM) induced by AGEs. Methods: Logarithmic phase HMCs were divided into blank group, model group, drug group and positive group. Blank group was not given any induction and intervention; model group, drug group and positive group was induced by AGEs(200mg/L); the drug group was intervened by low, medium and high dose(25,75,150mg/L) of GP at the same time, while positive group was given 0.1mmol/L aminoguanidine hydrochloride, all of which were cultured for 72 h. The inhibition of HMCs proliferation in each group was observed by MTT assay; the expression of nuclear factor κB(NF-κB) was detected by western blotting; the expression of TGF-β1 and PDGF-BB m RNA were detected by Semiquantitative RT-PCR. Results: in the model group, AGEs can induce HMCs proliferation, NF-κB activation and increase the expression of TGF-β1 and PDGF-BB m RNA, there was statistically significant compared with the control group(P〈0.01); in the drug group, GP can inhibit the proliferation of HMCs induced by AGEs, inhibit NF-κB activation and down-regulates the expression of TGF-β1, PDGF-BB m RNA, there was statistically significant compared with the model(P〈0.01). Conclusion: GP has a protective effect for HMCs cultured by AGEs, GP can inhibit the activation of NF-κB and down-regulates the expression of TGF-β1, PDGF-BB m RNA,thereby reducing the ECM secretion and aggregation to delay the progression of DN.
出处
《中华中医药杂志》
CAS
CSCD
北大核心
2015年第12期4478-4481,共4页
China Journal of Traditional Chinese Medicine and Pharmacy
基金
广西自然科学基金项目(No.2013GXNSFAA019197)
桂林市科学研究与技术开发计划项目(No.20120121-1-1)~~